Global Smart Biopsy Devices Market 2022-2028
A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. According to Gen Consulting Company, the global smart biopsy devices market is projected to reach USD 3,552 million, recording a CAGR of approximately 4.3 percent from 2022 to 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart biopsy devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart biopsy devices industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for smart biopsy devices can be segmented by application: breast cancer, prostate cancer, skin cancer, liver cancer, others. Smart biopsy devices market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
By application:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook